QPPV.COM KNOWLEDGE ASSESSMENT

Drug-Induced Kidney Injury: Renal Safety Assessment in Clinical Development and Pharmacovigilance

Test your understanding of the concepts covered by Drug-Induced Kidney Injury: Renal Safety Assessment in Clinical Development and Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A participant develops persistent new proteinuria with stable serum creatinine. What is the most appropriate professional response?

Dismiss the finding because filtration is preserved Assume it is structural glomerular injury caused by the investigational drug Evaluate baseline proteinuria, albuminuria, persistence, systemic disease, blood pressure, sediment, and concomitant medicines Classify it as AKI solely because urinary protein is increased

Question 2 of 10 A clinical-trial participant develops a modest increase in serum creatinine without proteinuria, urinary abnormalities, symptoms, or a rise in tubular injury biomarkers. A known pharmacological effect of the investigational drug is inhibition of creatinine tubular secretion. What is the most appropriate initial interpretation?

The finding is automatically structural nephrotoxicity The finding may represent pseudo-nephrotoxicity and requires contextual evaluation The finding should be disregarded because creatinine is not useful in renal safety assessment The finding proves that glomerular filtration has permanently declined

Question 3 of 10 A participant develops vomiting, diarrhoea, hypotension, oliguria, and rising creatinine while receiving an investigational medicine. What is the most appropriate causality approach?

Attribute the event to the investigational medicine solely because exposure preceded the event Exclude the medicine as a possible contributor because volume depletion is present Assess volume depletion and hypotension as competing or interacting explanations while evaluating the full exposure and clinical course Classify the event as structural tubular injury without further review

Question 4 of 10 Which scenario most strongly suggests that an apparent renal signal may be related to altered creatinine handling rather than structural injury?

Creatinine rises with new proteinuria, urinary abnormalities, and tubular biomarker elevation Creatinine rises reversibly, with no injury biomarker increase or clinical evidence of damage, and the drug is known to inhibit creatinine secretion Creatinine rises with oliguria, hypotension, and severe tubular abnormalities Creatinine rises with haematuria, oedema, and marked albuminuria

Question 5 of 10 What is the principal distinction between serum creatinine and KIM-1 in renal safety assessment?

Serum creatinine primarily reflects filtration, whereas KIM-1 is associated with tubular injury Serum creatinine reflects glomerular injury, whereas KIM-1 measures hydration Both are interchangeable direct measures of clinically significant nephrotoxicity KIM-1 is a demographic variable used to calculate eGFR

Question 6 of 10 Why should an elevated NGAL result not be interpreted automatically as proof of drug-induced tubular injury?

NGAL can be influenced by conditions beyond a narrowly defined drug-induced tubular injury phenotype NGAL is only produced by skeletal muscle NGAL measures serum albumin rather than renal injury NGAL is always invalid when serum creatinine is normal

Question 7 of 10 Which combination provides the strongest rationale for investigating a possible drug-related tubular injury signal?

Isolated creatinine elevation with no temporal relationship or clinical information Treatment-emergent tubular biomarker elevation, rising creatinine, plausible latency, no strong competing cause, and improvement after withdrawal Long-standing proteinuria documented before treatment with stable renal function A low serum creatinine in a participant with very low muscle mass

Question 8 of 10 Which urinary finding is most directly associated with a possible glomerular filtration-barrier abnormality?

Albuminuria Reduced urine volume caused by inaccurate collection Urinary crystalluria alone A change in serum cystatin C

Question 9 of 10 Why is urine output an important complement to serum creatinine in AKI assessment?

Urine output can indicate acute deterioration before a substantial serum creatinine change occurs Urine output directly identifies the responsible medicinal product Urine output is unaffected by diuretics, fluids, obstruction, or measurement quality Urine output replaces the need to review baseline kidney function

Question 10 of 10 Which documentation approach would best support an inspection-ready medical assessment of a suspected renal safety signal?

Document only that creatinine increased and the event was considered related Document baseline status, trajectory, urinary findings, biomarkers, exposure, competing causes, dechallenge, outcome, and the reasoning for the conclusion Document only the adverse-event term selected in the safety database Document the final causality category without recording the underlying data

Drug-Induced Kidney Injury: Renal Safety Assessment in Clinical Development and Pharmacovigilance

Cookie Settings